Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three ...

Exciting news for entrepreneurs and fans of innovation — Shark Tank India is back for Season 4, with the shooting officially underway! The much-anticipated reality series, known for bringing Indian ...

Gilead Sciences GILD has entered into licensing deals with six pharmaceutical companies to manufacture and supply a cheaper ...

Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...

On Thursday, 1120 stocks advanced, 2864 declined and 92 remained unchanged, with an advance decline ratio 0.39 on the Bombay Stock Exchange (BSE), indicating negative closing of stocks in broader ...

Shark Tank India’s former co-judge Ashneer Grover is not new to controversies. Lets look at three instances where he got ...

Emcure Pharmaceuticals on Thursday said it has signed a royalty-free voluntary licensing agreement with Gilead Sciences ...

Gilead's licensing agreement for lenacapavir a move to preserve its monopoly, alleges TWN: Our Bureau, New Delhi Thursday, October 3, 2024, 12:20 Hrs [IST] Third World Network (TW ...

Emcure Pharmaceuticals has partnered with Gilead Sciences to produce and distribute generic lenacapavir, an HIV treatment ...

Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...

AMFI is set to release its updated stock categorization in early January 2025. With anticipated changes in market cap ...